These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 1374103)
1. IFN-gamma-producing ability as a possible marker for the protective T cells against Mycobacterium bovis BCG in mice. Kawamura I; Tsukada H; Yoshikawa H; Fujita M; Nomoto K; Mitsuyama M J Immunol; 1992 May; 148(9):2887-93. PubMed ID: 1374103 [TBL] [Abstract][Full Text] [Related]
2. T cell subsets and IFN-gamma production in resistance to systemic candidosis in immunized mice. Cenci E; Romani L; Vecchiarelli A; Puccetti P; Bistoni F J Immunol; 1990 Jun; 144(11):4333-9. PubMed ID: 1971296 [TBL] [Abstract][Full Text] [Related]
3. Involvement of natural killer cells in nitric oxide production by spleen cells after stimulation with Mycobacterium bovis BCG. Study of the mechanism of the different abilities of viable and killed BCG. Yang J; Kawamura I; Zhu H; Mitsuyama M J Immunol; 1995 Dec; 155(12):5728-35. PubMed ID: 7499860 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of interferon-gamma production in killed BCG-pretreated mice after stimulation with staphylococcal enterotoxin A]. Mizukoshi N; Ishihara C; Yamamoto K; Kato K Kekkaku; 1989 Aug; 64(8):499-509. PubMed ID: 2509777 [TBL] [Abstract][Full Text] [Related]
5. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. Nabors GS; Tarleton RL J Immunol; 1991 May; 146(10):3591-8. PubMed ID: 1902857 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of viable and killed bacteria on IL-12 expression of macrophages. Song F; Matsuzaki G; Mitsuyama M; Nomoto K J Immunol; 1996 Apr; 156(8):2979-84. PubMed ID: 8609419 [TBL] [Abstract][Full Text] [Related]
8. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells. Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269 [TBL] [Abstract][Full Text] [Related]
9. [Novel vaccines against M. tuberculosis]. Okada M Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920 [TBL] [Abstract][Full Text] [Related]
10. Endotoxin-induced interferon-gamma production in culture cells derived from BCG-infected C3H/HeJ mice. Matsumura H; Nakano M J Immunol; 1988 Jan; 140(2):494-500. PubMed ID: 3121747 [TBL] [Abstract][Full Text] [Related]
11. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. Caruso AM; Serbina N; Klein E; Triebold K; Bloom BR; Flynn JL J Immunol; 1999 May; 162(9):5407-16. PubMed ID: 10228018 [TBL] [Abstract][Full Text] [Related]
12. Difference in the functional maturation of T cells against Listeria monocytogenes in lymph nodes and spleen. Serushago BA; Mitsuyama M; Handa T; Muramori K; Koga T; Nomoto K Immunology; 1992 Feb; 75(2):238-44. PubMed ID: 1551686 [TBL] [Abstract][Full Text] [Related]
13. Synergistic role of CD4+ and CD8+ T lymphocytes in IFN-gamma production and protective immunity induced by an attenuated Toxoplasma gondii vaccine. Gazzinelli RT; Hakim FT; Hieny S; Shearer GM; Sher A J Immunol; 1991 Jan; 146(1):286-92. PubMed ID: 1670604 [TBL] [Abstract][Full Text] [Related]
14. Induction by killed Listeria monocytogenes of effector T cells mediating delayed-type hypersensitivity but not protection in mice. Koga T; Mitsuyama M; Handa T; Yayama T; Muramori K; Nomoto K Immunology; 1987 Oct; 62(2):241-8. PubMed ID: 2445666 [TBL] [Abstract][Full Text] [Related]
15. [Analysis of antigen-specific proliferation and IL-2/IL-4 production of spleen cells from mice infected with Mycobacterium bovis BCG]. Teruya K; Kawakami K; Tohyama M; Saito A Kekkaku; 1995 Apr; 70(4):293-9. PubMed ID: 7760538 [TBL] [Abstract][Full Text] [Related]
16. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells. Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230 [TBL] [Abstract][Full Text] [Related]
17. Priming but not boosting with plasmid DNA encoding mycolyl-transferase Ag85A from Mycobacterium tuberculosis increases the survival time of Mycobacterium bovis BCG vaccinated mice against low dose intravenous challenge with M. tuberculosis H37Rv. Romano M; D'Souza S; Adnet PY; Laali R; Jurion F; Palfliet K; Huygen K Vaccine; 2006 Apr; 24(16):3353-64. PubMed ID: 16488518 [TBL] [Abstract][Full Text] [Related]
18. [Immunogenicity of interleukin 12 and DNA vaccine prime-BCG boost against Mycobacterium tuberculosis]. Gao L; Bao L; Hao M; Zhang L; Qin ZF Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Jul; 39(4):535-9. PubMed ID: 18798487 [TBL] [Abstract][Full Text] [Related]
19. The role of B cells in in vitro induction of IFN-gamma-producing CD4+ T cells specific to Listeria monocytogens: positive and IL-10-mediated negative regulation. Song F; Matsuzaki G; Mitsuyama M; Nomoto K Cell Immunol; 1994 Sep; 157(2):403-14. PubMed ID: 7915202 [TBL] [Abstract][Full Text] [Related]
20. Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response. Parajuli P; Pisarev V; Sublet J; Steffel A; Varney M; Singh R; LaFace D; Talmadge JE Cancer Res; 2001 Nov; 61(22):8227-34. PubMed ID: 11719454 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]